Soleno Therapeutics (SLNO) Inventory Average (2015 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Inventory Average of $16.2 million for Q1 2026, up 49.01% quarter-over-quarter from $10.8 million in Q4 2025.
Soleno Therapeutics (SLNO) Inventory Average (2015 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Inventory Average for 5 consecutive years, with $16.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average changed N/A year-over-year to $16.2 million; the TTM figure through Mar 2026 stood at $16.2 million (changed N/A YoY), while the FY2015 annual figure was $330172.0, changed N/A from the prior year.
- Inventory Average grew to $16.2 million in Q1 2026 per SLNO's latest filing, from $10.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $16.2 million in Q1 2026 and bottomed at $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 16.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.17 Mn |
| Dec 31, 2025 | 10.85 Mn |
| Sep 30, 2025 | 4.51 Mn |
| Jun 30, 2017 | 509,500.00 |
| Sep 30, 2016 | 738,500.00 |
| Jun 30, 2016 | 713,500.00 |
| Mar 31, 2016 | 602,004.00 |
| Dec 31, 2015 | 463,504.00 |
| Sep 30, 2015 | 326,500.00 |
| Jun 30, 2015 | 241,500.00 |
| Mar 31, 2015 | 157,668.00 |